Marshall Wace’s MiMedx Group MDXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$789K Sell
204,856
-1,656,290
-89% -$6.04M ﹤0.01% 2319
2026
Q1
$7.35M Buy
1,861,146
+479,858
+35% +$2.42M 0.01% 1116
2025
Q4
$9.35M Buy
1,381,288
+1,238,132
+865% +$8.68M 0.01% 898
2025
Q3
$999K Sell
143,156
-236,006
-62% -$1.64M ﹤0.01% 1946
2025
Q2
$2.32M Buy
+379,162
New +$2.52M ﹤0.01% 1490
2025
Q1
Sell
-348,747
Closed -$3.35M 2900
2024
Q4
$3.35M Buy
348,747
+220
+0.1% +$1.71K ﹤0.01% 1238
2024
Q3
$2.06M Buy
348,527
+49,709
+17% +$329K ﹤0.01% 1352
2024
Q2
$2.07M Buy
298,818
+3,223
+1% +$22.7K ﹤0.01% 1353
2024
Q1
$2.28M Sell
295,595
-35,899
-11% -$289K ﹤0.01% 1303
2023
Q4
$2.91M Sell
331,494
-227,010
-41% -$1.66M ﹤0.01% 1085
2023
Q3
$4.07M Buy
558,504
+325,927
+140% +$2.43M 0.01% 950
2023
Q2
$1.54M Sell
232,577
-89,958
-28% -$459K ﹤0.01% 1528
2023
Q1
$1.1M Buy
+322,535
New +$1.25M ﹤0.01% 1763
2021
Q1
Sell
-150,447
Closed -$1.37M 2709
2020
Q4
$1.37M Buy
+150,447
New +$1.08M 0.01% 1086
2019
Q1
Sell
-3,538,354
Closed -$6.33M 1929
2018
Q4
$6.33M Buy
+3,538,354
New +$19.6M 0.06% 380
2015
Q3
Sell
-123,623
Closed -$1.43M 1009
2015
Q2
$1.43M Buy
123,623
+72,802
+143% +$749K 0.02% 534
2015
Q1
$529K Buy
+50,821
New +$476K 0.01% 662

Other funds holding MDXG

Marshall Wace's MDXG Position: Q2 2026 in Review

Marshall Wace reduced its MiMedx Group (MDXG) stake by 89% in Q2 2026, selling an estimated $6.04M and leaving 204,856 shares worth $789K. The position accounts for ﹤0.01% of the portfolio, ranked #2319.

Marshall Wace first reported a position in MDXG in Q1 2015 and has held it in 17 quarters since. The position peaked at $9.35M in Q4 2025. 226 funds tracked by Wall St. Rank hold MDXG as of Q2 2026.

  • Marshall Wace held 204,856 shares of MiMedx Group worth $789K as of Q2 2026.
  • Marshall Wace sold 1,656,290 MiMedx Group shares in Q2 2026, an estimated $6.04M.
  • MiMedx Group made up ﹤0.01% of Marshall Wace's portfolio in Q2 2026, its #2319 holding.
  • Marshall Wace first reported a position in MiMedx Group in Q1 2015 and has held it in 17 quarters since.
  • Marshall Wace's MiMedx Group position peaked at $9.35M in Q4 2025.
  • 226 funds tracked by Wall St. Rank held MiMedx Group as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.